[1] 王晓琳,谢青.非酒精性脂肪肝的继发因素及诊断[J].肝脏,2022,27(1):109-113. [2] 王雨,杨志然,陈润花,等.中国儿童非酒精性脂肪性肝病患病率的Meta分析[J].中国儿童保健杂志,2022,30(7):764-769. [3] Saha M, Hossain MZ, Gope S, et al. Prevalence of sonologically detected non-alcoholic fatty liver disease among school children of sylhet city[J]. Mymensingh Med J, 2022, 31(2): 412-415. [4] Sadeghian M, Vafadar M, Torabi A, et al. Prevalence of fatty liver and its related factors in children[J]. J Family Med Prim Care., 2022, 11(9): 5604-5608. [5] 何春霞,蔡海芳,刘晟,等.浙西南地区肥胖儿童的非酒精性脂肪肝的发生特点危险因素及针对性预防措施研究[J].中国妇幼保健,2020,35(20):3821-3824. [6] 郑冬梅,梁学军,靳景璐,等.中国儿童肥胖的评估、治疗和预防指南[J].中国妇幼健康研究,2021,32(12):1716-1722. [7] 王琴,魏来.国内外儿童与成人非酒精性脂肪性肝病诊疗指南的比较与解析[J].临床肝胆病杂志,2017,33(12):2265-2269. [8] Lu YL, Li WY, Gong XB, et al. Prevalence of fatty liver among children under multiple machine learning models[J]. South Med J, 2022, 115(8): 622-627. [9] Brandt S, v Schnurbein J, Denzer C, et al. Lower circulating leptin levels are related to non-alcoholic fatty liver disease in children with obesity[J]. Front Endocrinol, 2022, 23(13): e881982. [10] 张毅,廖燕薇,麻静.超重肥胖儿童泌乳素水平及其与非酒精性脂肪肝发病风险的关系[J].中国优生与遗传杂志,2022,30(6):1040-1044. [11] Zorena K, Jachimowicz DO, Ślezak D, et al. Adipokines and obesity potential link to metabolic disorders and chronic complications[J]. Int J Mol Sci, 2020, 21(10): 3570. [12] Sheng G, Lu S, Xie Q, et al. The usefulness of obesity and lipid-related indices to predict the presence of non-alcoholic fatty liver disease[J]. Lipids Health Dis, 2021, 20(1): 134. [13] Shi Y, Hu L, Li M, et al. Relationship between the lipid accumulation product index and arterial stiffness in the Chinese population with hypertension: a report from the China H-type hypertension registry study[J]. Front Cardiovasc Med, 2022, 21(8): e760361. [14] Golabi S, Ajloo S, Maghsoudi F, et al. Associations between traditional and non-traditional anthropometric indices and cardiometabolic risk factors among inpatients with type 2 diabetes mellitus: a cross-sectional study[J]. J Int Med Res, 2021, 49(10): 030006052110499. [15] Wang Y, Liu WM, Sun LL, et al. A novel indicator, childhood lipid accumulation product, is associated with hypertension in Chinese children and adolescents[J]. Hypertens Res, 2020, 43(3): 305-312. [16] 段小龙,王丽明,康玉蓉,等.人体测量指标预测肥胖儿童非酒精性脂肪肝的研究[J].中国儿童保健杂志,2022,30(5):475-479. [17] Crimmins NA, Mouzaki M, Delbello MP, et al. A novel indicator, childhood lipid accumulation product, is associated with hypertension in Chinese children and adolescents[J]. Diabetes, 2022, 71(1): 1432. [18] Ma XF, Liu SS, Zhang J, et al. Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis[J]. BMC Gastroenterol, 2020, 20(15): 862-873. [19] Chao GQ, Chen LY. Study on the independent effect of thyroid hormone based on uric acid level on NAFLD[J]. Health Popul Nutr, 2021, 40(1): 21. [20] Hoi J, Joe H, Oh JE, et al. The correlation between NAFLD and serum uric acid to serum creatinine ratio[J]. PLoS One, 2023, 18(7): e0288666. [21] Park H, Park KY, Kim M, et al. Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans[J]. Asian Biomed, 2022, 28(1): 15-22. [22] Jung JY, Shim JJ, Park SK, et al. Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population[J]. Hepatol Int, 2019, 13(2): 222-233. [23] Armandi A, Younes R, Caviglia GP, et al. Increased serum ferritin levels predict long-term mortality in patients with NAFLD[J]. Digest Liver Dis, 2021, 53(S1): 28. |